|
|
|
|
| LEADER |
00000cam a22000007i 4500 |
| 001 |
SCIDIR_on1371253740 |
| 003 |
OCoLC |
| 005 |
20231120010728.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
230227t20232023ne a ob 001 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d UKAHL
|d UKMGB
|d OCLCF
|d MMU
|d OCLCO
|
| 015 |
|
|
|a GBC340804
|2 bnb
|
| 016 |
7 |
|
|a 020966830
|2 Uk
|
| 020 |
|
|
|z 9780323855389
|q (print)
|
| 020 |
|
|
|a 9780323900645
|q (ePub ebook)
|
| 020 |
|
|
|a 032390064X
|q (ePub ebook)
|
| 035 |
|
|
|a (OCoLC)1371253740
|
| 050 |
|
4 |
|a RC365
|
| 060 |
|
4 |
|a WL 358.5
|
| 082 |
0 |
4 |
|a 616.8/3
|2 23/eng/20230227
|
| 245 |
0 |
0 |
|a Precision medicine in neurodegenerative disorders.
|n Part I /
|c edited by Alberto J. Espay.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier,
|c [2023]
|
| 264 |
|
4 |
|c �2023
|
| 300 |
|
|
|a 1 online resource (xviii, 269 pages) :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Handbook of clinical neurology ;
|v volume 192
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ProQuest, viewed September 22, 2023).
|
| 505 |
0 |
0 |
|t The definition of precision medicine in neurodegenerative disorders and the one disease-many-diseases tension --
|t Models of precision medicine for neurodegeneration --
|t Pathology vs pathogenesis: Rationale and pitfalls in the clinicopathology model of neurodegeneration --
|t Mixed pathology as a rule, not exception: Time to reconsider disease nosology? --
|t Neurodegenerative disorders: From clinicopathology convergence to systems biology divergence --
|t The emergence of genotypic divergence and future precision medicine applications --
|t Lessons from other fields of medicine, Part 1: Breast cancer --
|t Lessons from other fields of medicine, Part 2: Cystic fibrosis --
|t Lessons learned from evolving frameworks in adult glioblastoma --
|t Finding the falsification threshold of the toxic proteinopathy hypothesis in neurodegeneration --
|t The theoretical problems of "prodrome" and "phenoconversion" in neurodegeneration --
|t The dilemma between milestones of progression vs. clinical scales in Parkinson disease --
|t Biomarkers of diagnosis, prognosis, pathogenesis, response to therapy: Convergence or divergence? Lessons from Alzheimer Disease and synucleinopathies --
|t Challenges in the study of individuals at risk for Parkinson disease --
|t The challenging quest of neuroimaging: From clinical to molecular-based subtyping of Parkinson disease and atypical parkinsonisms
|
| 650 |
|
0 |
|a Nervous system
|x Degeneration.
|
| 650 |
|
0 |
|a Precision medicine.
|
| 650 |
|
2 |
|a Neurodegenerative Diseases
|x therapy
|0 (DNLM)D019636Q000628
|
| 650 |
|
2 |
|a Precision Medicine
|0 (DNLM)D057285
|
| 650 |
|
6 |
|a M�edecine de pr�ecision.
|0 (CaQQLa)000288678
|
| 650 |
|
7 |
|a Nervous system
|x Degeneration
|2 fast
|0 (OCoLC)fst01036090
|
| 700 |
1 |
|
|a Espay, Alberto J.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Precision medicine in neurodegenerative disorders. Part I.
|d Amsterdam : Elsevier, 2023
|z 9780323855389
|w (OCoLC)1376270027
|
| 830 |
|
0 |
|a Handbook of clinical neurology ;
|v v. 192.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/handbooks/00729752/192
|z Texto completo
|
